CorMedix CRMD Stock
11.13 USD
{{ price }}
-4.216870%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
Tech Market Middle
Market Cap
872.03M USD
LOW - HIGH [24H]
10.95
-
11.9 USD
VOLUME [24H]
2.14M USD
{{ volume }}
P/E Ratio
14.26
Earnings per share
0.78 USD
CorMedix Price Chart
CorMedix CRMD Financial and Trading Overview
| CorMedix stock price | 11.13 USD |
| Previous Close | 11.07 USD |
| Open | 11.1 USD |
| Bid | 10.86 USD x 1300 |
| Ask | 10.91 USD x 300 |
| Day's Range | 10.84 - 11.13 USD |
| 52 Week Range | 3.61 - 17.43 USD |
| Volume | 1.41M USD |
| Avg. Volume | 1.99M USD |
| Market Cap | 808.3M USD |
| Beta (5Y Monthly) | 1.608 |
| PE Ratio (TTM) | 43.44 |
| EPS (TTM) | 0.78 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 19 USD |
CRMD Valuation Measures
| Enterprise Value | 758.57M USD |
| Trailing P/E | 43.44 |
| Forward P/E | 22.625 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.791201 |
| Price/Book (mrq) | 6.3995285 |
| Enterprise Value/Revenue | 9.189 |
| Enterprise Value/EBITDA | 50.832 |
Trading Information
CorMedix Stock Price History
| Beta (5Y Monthly) | 1.608 |
| 52-Week Change | 129.11% |
| S&P500 52-Week Change | 13.16% |
| 52 Week High | 17.43 USD |
| 52 Week Low | 3.61 USD |
| 50-Day Moving Average | 12.69 USD |
| 200-Day Moving Average | 10.5 USD |
CRMD Share Statistics
| Avg. Volume (3 month) | 1.99M USD |
| Avg. Daily Volume (10-Days) | 1.36M USD |
| Shares Outstanding | 74.43M |
| Float | 67.09M |
| Short Ratio | 6.18 |
| % Held by Insiders | 1.18% |
| % Held by Institutions | 37.18% |
| Shares Short | 8.59M |
| Short % of Float | 12.81% |
| Short % of Shares Outstanding | 12.65% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | March 31, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 20.81% |
| Operating Margin (ttm) | 51.49% |
| Gross Margin | 95.19% |
| EBITDA Margin | 18.07% |
Management Effectiveness
| Return on Assets (ttm) | 8.31% |
| Return on Equity (ttm) | 19.87% |
Income Statement
| Revenue (ttm) | 82.55M USD |
| Revenue Per Share (ttm) | 1.36 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 78.59M USD |
| EBITDA | 14.92M USD |
| Net Income Avi to Common (ttm) | 17.18M USD |
| Diluted EPS (ttm) | 0.25 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 77.5M USD |
| Total Cash Per Share (mrq) | 1.14 USD |
| Total Debt (mrq) | 476.59K USD |
| Total Debt/Equity (mrq) | 0.42 USD |
| Current Ratio (mrq) | 4.212 |
| Book Value Per Share (mrq) | 1.697 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13567856 USD |
| Levered Free Cash Flow (ttm) | -21068416 USD |
Profile of CorMedix
| Country | United States |
| State | NJ |
| City | Berkeley Heights |
| Address | 300 Connell Drive |
| ZIP | 07922 |
| Phone | 908 517 9500 |
| Website | https://www.cormedix.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 64 |
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Q&A For CorMedix Stock
What is a current CRMD stock price?
CorMedix CRMD stock price today per share is 11.13 USD.
How to purchase CorMedix stock?
You can buy CRMD shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CorMedix?
The stock symbol or ticker of CorMedix is CRMD.
Which industry does the CorMedix company belong to?
The CorMedix industry is Biotechnology.
How many shares does CorMedix have in circulation?
The max supply of CorMedix shares is 78.35M.
What is CorMedix Price to Earnings Ratio (PE Ratio)?
CorMedix PE Ratio is 14.26923200 now.
What was CorMedix earnings per share over the trailing 12 months (TTM)?
CorMedix EPS is 0.78 USD over the trailing 12 months.
Which sector does the CorMedix company belong to?
The CorMedix sector is Healthcare.
CorMedix CRMD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23724.96 USD — |
+0.61
|
9.88B USD — | 23628.82 USD — | 23946.23 USD — | — - | 9.88B USD — |
| US Tech Global Market Composite NQGM | 2309.83 USD — |
+1.58
|
— — | 2282.44 USD — | 2312.75 USD — | — - | — — |
| US Tech Health Care IXHC | 1115.96 USD — |
+0.87
|
— — | 1099.74 USD — | 1117.62 USD — | — - | — — |
- {{ link.label }} {{link}}